Current siRNA targets in atherosclerosis and aortic aneurysm

Discovery Medicine

Volumn 17, Issue 95, 2014, Pages 233-246

  Pradhan Nabzdyk, Leena ^a   Huang, Chenyu ^a   LoGerfo, Frank W ^a   Nabzdyk, Christoph S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; IMMUNOLOGIC FACTOR;

AORTA ANEURYSM; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; EXTRACELLULAR MATRIX; FEASIBILITY STUDY; GENE SILENCING; HUMAN; HYPERCHOLESTEROLEMIA; NONHUMAN; PATHOPHYSIOLOGY; RECEPTOR UPREGULATION; REDUNDANCY ANALYSIS; SIGNAL TRANSDUCTION; VALIDATION PROCESS; VASCULAR DISEASE; ANIMAL; CELL MEMBRANE; CLINICAL TRIAL (TOPIC); DRUG DELIVERY SYSTEM; GENETIC PROCEDURES; GENETICS; METABOLISM; MOUSE; RNA INTERFERENCE;

ANIMALS; AORTIC ANEURYSM; ATHEROSCLEROSIS; CELL MEMBRANE; CLINICAL TRIALS AS TOPIC; DRUG DELIVERY SYSTEMS; GENE SILENCING; GENETIC TECHNIQUES; HUMANS; IMMUNOLOGIC FACTORS; MICE; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84940475086     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (112)

1. Arnold JD, Mountain DJ, Freeman MB, Kirkpatrick SS, Stevens SL, Goldman MH, Grandas OH. Smooth muscle cell polymeric transfection is an efficient alternative to traditional methods of experimental gene therapy. J Surg Res 177(1):178-184, 2012.
2. Bayat H, Schroder K, Pimentel DR, Brandes RP, Verbeuren TJ, Cohen RA, Jiang B. Activation of thromboxane receptor modulates interleukin-1beta-induced monocyte adhesion-a novel role of Nox1. Free Radic Biol Med 52(9):1760-1766, 2012.
3. Bhasin M, Huang Z, Pradhan-Nabzdyk L, Malek JY, Logerfo PJ, Contreras M, Guthrie P, Csizmadia E, Andersen N, Kocher O, Ferran C, Logerfo FW. Temporal network based analysis of cell specific vein graft transcriptome defines key pathways and hub genes in implantation injury. PLoS One 7(6):e39123, 2012.
4. Bochem AE, Van Wijk DF, Holleboom AG, Duivenvoorden R, Motazacker MM, Dallinga-Thie GM, De Groot E, Kastelein JJ, Nederveen AJ, Hovingh GK, Stroes ES. ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden. Eur Heart J 34(4):286-291, 2013.
5. Boye K, Maelandsmo GM. S100A4 and metastasis: a small actor playing many roles. Am J Pathol 176(2):528-535, 2010.
6. Brisset AC, Hao H, Camenzind E, Bacchetta M, Geinoz A, Sanchez JC, Chaponnier C, Gabbiani G, Bochaton-Piallat ML. Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ Res 100(7):1055-1062, 2007.
7. Butoi ED, Gan AM, Manduteanu I, Stan D, Calin M, Pirvulescu M, Koenen RR, Weber C, Simionescu M. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules. Biochim Biophys Acta 1813(12):2026-2035, 2011.
8. Cao J, Geng L, Wu Q, Wang W, Chen Q, Lu L, Shen W, Chen Y. Spatiotemporal expression of matrix metalloproteinases (MMPs) is regulated by the Ca2+-signal transducer S100A4 in the pathogenesis of thoracic aortic aneurysm. PLoS One 8(7):e70057, 2013.
9. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, Tontonoz P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7(1):161-171, 2001.
10. Cheng XW, Song H, Sasaki T, Hu L, Inoue A, Bando YK, Shi GP, Kuzuya M, Okumura K, Murohara T. Angiotensin type 1 receptor blocker reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Hypertension 57(5):981-989, 2011.
11. Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T, Perez J, Chiesa J, Warrington S, Tranter E, Munisamy M, Falzone R, Harrop J, Cehelsky J, Bettencourt BR, Geissler M, Butler JS, Sehgal A, Meyers RE, Chen Q, et al. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med 369(9):819-829, 2013.
12. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Berceli SA, Demasi RJ, Samson RH, Berman SS, Investigators PI. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43(4):742-751; discussion 751, 2006.
13. Cotoi OS, Duner P, Ko N, Hedblad B, Nilsson J, Bjorkbacka H, Schiopu A. Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals. Arterioscler Thromb Vasc Biol 34(1):202-210, 2014.
14. Davis V, Persidskaia R, Baca-Regen L, Itoh Y, Nagase H, Persidsky Y, Ghorpade A, Baxter BT. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 18(10):1625-1633, 1998.
15. De Waard V, Bot I, De Jager SC, Talib S, Egashira K, De Vries MR, Quax PH, Biessen EA, Van Berkel TJ. Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differently. Atherosclerosis 211(1):84-89, 2010.
16. Dimusto PD, Lu G, Ghosh A, Roelofs KJ, Sadiq O, Mcevoy B, Su G, Laser A, Bhamidipati CM, Ailawadi G, Henke PK, Eliason JL, Upchurch GR Jr. Increased JNK in males compared with females in a rodent model of abdominal aortic aneurysm. J Surg Res 176(2):687-695, 2012.
17. Dong Z, An F, Wu T, Zhang C, Zhang M, Zhang Y, An G, An F. PTX3, a key component of innate immunity, is induced by SAA via FPRL1-mediated signaling in HAECs. J Cell Biochem 112(8):2097-2105, 2011.
18. Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3(4):318-329, 2004.
19. Dwivedi A, Slater SC, George SJ. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation. Cardiovasc Res 81(1):178-186, 2009.
20. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411(6836):494-498, 2001.
21. Feaver RE, Gelfand BD, Wang C, Schwartz MA, Blackman BR. Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation. Circ Res 106(11):1703-1711, 2010.
22. Fu Y, Moore XL, Lee MK, Fernandez-Rojo MA, Parat MO, Parton RG, Meikle PJ, Sviridov D, Chin-Dusting JP. Caveolin-1 plays a critical role in the differentiation of monocytes into macrophages. Arterioscler Thromb Vasc Biol 32(9):e117-125, 2012.
23. Funk SD, Yurdagul A Jr, Albert P, Traylor JG Jr, Jin L, Chen J, Orr AW. EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis. Arterioscler Thromb Vasc Biol 32(3):686-695, 2012.
24. Geng H, Wang A, Rong G, Zhu B, Deng Y, Chen J, Zhong R. The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway. Mol Cell Biochem 342(1-2):201-206, 2010.
25. Ghosh A, Dimusto PD, Ehrlichman LK, Sadiq O, Mcevoy B, Futchko JS, Henke PK, Eliason JL, Upchurch GR Jr. The role of extracellular signal-related kinase during abdominal aortic aneurysm formation. J Am Coll Surg 215(5):668-680, 2012.
26. Ghosh A, Lu G, Su G, Mcevoy B, Sadiq O, Dimusto PD, Laser A, Futchko JS, Henke PK, Eliason JL, Upchurch GR Jr. Phosphorylation of AKT and abdominal aortic aneurysm formation. Am J Pathol 184(1):148-158, 2014.
27. Gray SP, Di Marco E, Okabe J, Szyndralewiez C, Heitz F, Montezano AC, De Haan JB, Koulis C, El-Osta A, Andrews KL, Chin-Dusting JP, Touyz RM, Wingler K, Cooper ME, Schmidt HH, Jandeleit-Dahm KA. NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation 127(18):1888-1902, 2013.
28. Ha YM, Lee DH, Kim M, Kang YJ. High glucose induces connective tissue growth factor expression and extracellular matrix accumulation in rat aorta vascular smooth muscle cells via extracellular signal-regulated kinase 1/2. Korean J Physiol Pharmacol 17(4):307-314, 2013.
29. Hahn C, Wang C, Orr AW, Coon BG, Schwartz MA. JNK2 promotes endothelial cell alignment under flow. PLoS One 6(8):e24338, 2011.
30. Harrington EO, Loffler J, Nelson PR, Kent KC, Simons M, Ware JA. Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells. J Biol Chem 272(11):7390-7397, 1997.
31. Hu Q, Zhang XJ, Liu CX, Wang XP, Zhang Y. PPARgamma1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice. J Vasc Res 47(1):69-79, 2010.
32. Inaba H, Hokamura K, Nakano K, Nomura R, Katayama K, Nakajima A, Yoshioka H, Taniguchi K, Kamisaki Y, Ooshima T, Umemura K, Murad F, Wada K, Amano A. Upregulation of S100 calcium-binding protein A9 is required for induction of smooth muscle cell proliferation by a periodontal pathogen. FEBS Lett 583(1):128-134, 2009.
33. Jagielska J, Kapopara PR, Salguero G, Scherr M, Schutt H, Grote K, Schieffer B, Bavendiek U. Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells. Arterioscler Thromb Vasc Biol 32(5):1280-1288, 2012.
34. Jellinghaus S, Poitz DM, Ende G, Augstein A, Weinert S, Stutz B, Braun-Dullaeus RC, Pasquale EB, Strasser RH. Ephrin-A1/EphA4-mediated adhesion of monocytes to endothelial cells. Biochim Biophys Acta 1833(10):2201-2211, 2013.
35. Ji Y, Liu J, Wang Z, Li Z. PPARgamma agonist rosiglitazone ameliorates LPS-induced inflammation in vascular smooth muscle cells via the TLR4/TRIF/IRF3/IP-10 signaling pathway. Cytokine 55(3):409-419, 2011.
36. Ji Y, Wang Z, Li Z, Liu J. Modulation of LPS-mediated inflammation by fenofibrate via the TRIF-dependent TLR4 signaling pathway in vascular smooth muscle cells. Cell Physiol Biochem 25(6):631-640, 2010.
37. Jialal I, Devaraj S. Antisense to protein kinase C-alpha and p47phox attenuates the pro-inflammatory effects of human C-reactive protein in macrophages of biobreeding diabetic rats. Diab Vasc Dis Res 9(4):315-319, 2012.
38. Jialal I, Kaur H, Devaraj S. Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats. J Diabetes Complications 27(1):23-28, 2013a.
39. Jialal I, Machha A, Devaraj S. Small interfering-RNA to protein kinase C-delta reduces the proinflammatory effects of human C-reactive protein in biobreeding diabetic rats. Horm Metab Res 45(4):326-328, 2013b.
40. Johnson JL, Dwivedi A, Somerville M, George SJ, Newby AC. Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler Thromb Vasc Biol 31(9):e35-e44, 2011.
41. Jung F, Haendeler J, Goebel C, Zeiher AM, Dimmeler S. Growth factor-induced phosphoinositide 3-OH kinase/Akt phosphorylation in smooth muscle cells: induction of cell proliferation and inhibition of cell death. Cardiovasc Res 48(1):148-157, 2000.
42. Kamiya K, Ryer E, Sakakibara K, Zohlman A, Kent KC, Liu B. Protein kinase C delta activated adhesion regulates vascular smooth muscle cell migration. J Surg Res 141(1):91-96, 2007.
43. Karunakaran D, Kockx M, Owen DM, Burnett JR, Jessup W, Kritharides L. Protein kinase C controls vesicular transport and secretion of apolipoprotein E from primary human macrophages. J Biol Chem 288(7):5186-5197, 2013.
44. Kim D, Lee D, Jang YL, Chae SY, Choi D, Jeong JH, Kim SH. Facial amphipathic deoxycholic acid-modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cells. Eur J Pharm Biopharm 81(1):14-23, 2012.
45. Kim J, Min JK, Park JA, Doh HJ, Choi YS, Rho J, Kim YM, Kwon YG. Receptor activator of nuclear factor kappaB ligand is a novel inducer of tissue factor in macrophages. Circ Res 107(7):871-876, 2010.
46. Kimura K, Cheng XW, Nakamura K, Inoue A, Hu L, Song H, Okumura K, Iguchi A, Murohara T, Kuzuya M. Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2. Clin Exp Pharmacol Physiol 37(11):1096-1101, 2010.
47. Kong L, Shen X, Lin L, Leitges M, Rosario R, Zou YS, Yan SF. PKCbeta promotes vascular inflammation and acceleration of atherosclerosis in diabetic ApoE null mice. Arterioscler Thromb Vasc Biol 33(8):1779-1787, 2013.
48. Kowalski PS, Leus NG, Scherphof GL, Ruiters MH, Kamps JA, Molema G. Targeted siRNA delivery to diseased microvascular endothelial cells: cellular and molecular concepts. IUBMB Life 63(8):648-658, 2011.
49. Kowalski PS, Lintermans LL, Morselt HW, Leus NG, Ruiters MH, Molema G, Kamps JA. Anti-VCAM-1 and anti-E-selectin SAINT-O-Somes for selective delivery of siRNA into inflammation-activated primary endothelial cells. Mol Pharm 10(8):3033-3044, 2013.
50. Kowalski PS, Zwiers PJ, Morselt HW, Kuldo JM, Leus NG, Ruiters MH, Molema G, Kamps JA. Anti-VCAM-1 SAINT-O-Somes enable endothelial-specific delivery of siRNA and downregulation of inflammatory genes in activated endothelium in vivo. J Control Release 176C:64-75, 2014.
51. Kowluru RA, Mohammad G, Dos Santos JM, Zhong Q. Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage. Diabetes 60(11):3023-3033, 2011.
52. Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, Shagdarsuren E, Lira SA, Weissman IL, Weber C, Jung S. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113(4):963-972, 2009.
53. Larroque-Cardoso P, Swiader A, Ingueneau C, Negre-Salvayre A, Elbaz M, Reyland ME, Salvayre R, Vindis C. Role of protein kinase C delta in ER stress and apoptosis induced by oxidized LDL in human vascular smooth muscle cells. Cell Death Dis 4:e520, 2013.
54. Leus NG, Talman EG, Ramana P, Kowalski PS, Woudenberg-Vrenken TE, Ruiters MH, Molema G, Kamps JA. Effective siRNA delivery to inflamed primary vascular endothelial cells by anti-E-selectin and anti-VCAM-1 PEGylated SAINT-based lipoplexes. Int J Pharm 459(1-2):40-50, 2014.
55. Leuschner F, Dutta P, Gorbatov R, Novobrantseva TI, Donahoe JS, Courties G, Lee KM, Kim JI, Markmann JF, Marinelli B, Panizzi P, Lee WW, Iwamoto Y, Milstein S, Epstein-Barash H, Cantley W, Wong J, Cortez-Retamozo V, Newton A, Love K, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol 29(11):1005-1010, 2011.
56. Li N, Mclaren JE, Michael DR, Clement M, Fielding CA, Ramji DP. ERK is integral to the IFN-gamma-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages. J Immunol 185(5):3041-3048, 2010.
57. Lin CS, Lin FY, Ho LJ, Tsai CS, Cheng SM, Wu WL, Huang CY, Lian CH, Yang SP, Lai JH. PKCdelta signalling regulates SR-A and CD36 expression and foam cell formation. Cardiovasc Res 95(3):346-355, 2012.
58. Lin FY, Chen YH, Lin YW, Tsai JS, Chen JW, Wang HJ, Chen YL, Li CY, Lin SJ. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation. Arterioscler Thromb Vasc Biol 26(12):2622-2629, 2006.
59. Liu HF, Cui KF, Wang JP, Zhang M, Guo YP, Li XY, Jiang C. Significance of ABCA1 in human carotid atherosclerotic plaques. Exp Ther Med 4(2):297-302, 2012a.
60. Liu N, Liu J, Ji Y, Lu P. Toll-like receptor 4 signaling mediates inflammatory activation induced by C-reactive protein in vascular smooth muscle cells. Cell Physiol Biochem 25(4-5):467-476, 2010.
61. Liu X, Lu G, Shen J. Silencing CX3CR1 production modulates the interaction between dendritic and endothelial cells. Mol Biol Rep 38(1):481-488, 2011.
62. Liu Z, Luo H, Zhang L, Huang Y, Liu B, Ma K, Feng J, Xie J, Zheng J, Hu J, Zhan S, Zhu Y, Xu Q, Kong W, Wang X. Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice. Circ Res 111(10):1261-1273, 2012b.
63. Luo DX, Cheng J, Xiong Y, Li J, Xia C, Xu C, Wang C, Zhu B, Hu Z, Liao DF. Static pressure drives proliferation of vascular smooth muscle cells via caveolin-1/ERK1/2 pathway. Biochem Biophys Res Commun 391(4):1693-1697, 2010.
64. Luo Y, Li SJ, Yang J, Qiu YZ, Chen FP. HMGB1 induces an inflammatory response in endothelial cells via the RAGE-dependent endoplasmic reticulum stress pathway. Biochem Biophys Res Commun 438(4):732-738, 2013.
65. Ma KL, Liu J, Wang CX, Ni J, Zhang Y, Wu Y, Lv LL, Ruan XZ, Liu BC. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation. Cardiovasc Res 100(3):450-460, 2013a.
66. Ma W, Liu Y, Ellison N, Shen J. Induction of C-X-C chemokine receptor type 7 (CXCR7) switches stromal cell-derived factor-1 (SDF-1) signaling and phagocytic activity in macrophages linked to atherosclerosis. J Biol Chem 288(22):15481-15494, 2013b.
67. Majmudar MD, Keliher EJ, Heidt T, Leuschner F, Truelove J, Sena BF, Gorbatov R, Iwamoto Y, Dutta P, Wojtkiewicz G, Courties G, Sebas M, Borodovsky A, Fitzgerald K, Nolte MW, Dickneite G, Chen JW, Anderson DG, Swirski FK, Weissleder R, et al. Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation 127(20):2038-2046, 2013.
68. Makinen PI, Yla-Herttuala S. Therapeutic gene targeting approaches for the treatment of dyslipidemias and atherosclerosis. Curr Opin Lipidol 24(2):116-122, 2013.
69. Mei S, Gu H, Ward A, Yang X, Guo H, He K, Liu Z, Cao W. p38 mitogen-activated protein kinase (MAPK) promotes cholesterol ester accumulation in macrophages through inhibition of macroautophagy. J Biol Chem 287(15):11761-11768, 2012.
70. Meng Z, Yan C, Deng Q, Dong X, Duan ZM, Gao DF, Niu XL. Oxidized low-density lipoprotein induces inflammatory responses in cultured human mast cells via Toll-like receptor 4. Cell Physiol Biochem 31(6):842-853, 2013.
71. Mo ZC, Xiao J, Liu XH, Hu YW, Li XX, Yi GH, Wang Z, Tang YL, Liao DF, Tang CK. AOPPs inhibits cholesterol efflux by down-regulating ABCA1 expression in a JAK/STAT signaling pathway-dependent manner. J Atheroscler Thromb 18(9):796-807, 2011.
72. Moreno JA, Sastre C, Madrigal-Matute J, Munoz-Garcia B, Ortega L, Burkly LC, Egido J, Martin-Ventura JL, Blanco-Colio LM. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes. Arterioscler Thromb Vasc Biol 33(3):612-620, 2013.
73. Nabzdyk CS, Chun M, Pradhan L, Logerfo FW. High throughput RNAi assay optimization using adherent cell cytometry. J Transl Med 9:48, 2011.
74. Nabzdyk CS, Chun M, Pradhan Nabzdyk L, Yoshida S, Logerfo FW. Differential susceptibility of human primary aortic and coronary artery vascular cells to RNA interference. Biochem Biophys Res Commun 425(2):261-265, 2012.
75. Nabzdyk CS, Chun MC, Oliver-Allen HS, Pathan SG, Phaneuf MD, You JO, Pradhan-Nabzdyk LK, Logerfo FW. Gene silencing in human aortic smooth muscle cells induced by PEI-siRNA complexes released from dip-coated electrospun poly(ethylene terephthalate) grafts. Biomaterials 35(9):3071-3079, 2014.
76. Naruse K, Rask-Madsen C, Takahara N, Ha SW, Suzuma K, Way KJ, Jacobs JR, Clermont AC, Ueki K, Ohshiro Y, Zhang J, Goldfine AB, King GL. Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes 55(3):691-698, 2006.
77. New SE, Goettsch C, Aikawa M, Marchini JF, Shibasaki M, Yabusaki K, Libby P, Shanahan CM, Croce K, Aikawa E. Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res 113(1):72-77, 2013.
78. Newman KM, Malon AM, Shin RD, Scholes JV, Ramey WG, Tilson MD. Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources. Connect Tissue Res 30(4):265-276, 1994a.
79. Newman KM, Ogata Y, Malon AM, Irizarry E, Gandhi RH, Nagase H, Tilson MD. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 14(8):1315-1320, 1994b.
80. Nishina K, Unno T, Uno Y, Kubodera T, Kanouchi T, Mizusawa H, Yokota T. Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol. Mol Ther 16(4):734-740, 2008.
81. Nolte A, Walker T, Schneider M, Kray O, Avci-Adali M, Ziemer G, Wendel HP. Small-interfering RNA-eluting surfaces as a novel concept for intravascular local gene silencing. Mol Med 17(11-12):1213-1222, 2011.
82. Palombo D, Maione M, Cifiello BI, Udini M, Maggio D, Lupo M. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta. J Cardiovasc Surg (Torino) 40(2):257-260, 1999.
83. Park DW, Lee HK, Lyu JH, Chin H, Kang SW, Kim YJ, Bae YS, Baek SH. TLR2 stimulates ABCA1 expression via PKC-eta and PLD2 pathway. Biochem Biophys Res Commun 430(3):933-937, 2013a.
84. Park DW, Lyu JH, Kim JS, Chin H, Bae YS, Baek SH. Role of JAK2-STAT3 in TLR2-mediated tissue factor expression. J Cell Biochem 114(6):1315-1321, 2013b.
85. Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, Thompson RW. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 23(2):336-346, 1996.
86. Rius C, Piqueras L, Gonzalez-Navarro H, Albertos F, Company C, Lopez-Gines C, Ludwig A, Blanes JI, Morcillo EJ, Sanz MJ. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II. Arterioscler Thromb Vasc Biol 33(1):96-104, 2013.
87. Salmon M, Johnston WF, Woo A, Pope NH, Su G, Upchurch GR Jr, Owens GK, Ailawadi G. KLF4 regulates abdominal aortic aneurysm morphology and deletion attenuates aneurysm formation. Circulation 128(11 Suppl 1):S163-S174, 2013.
88. Shen YH, Zhang L, Ren P, Nguyen MT, Zou S, Wu D, Wang XL, Coselli JS, Lemaire SA. AKT2 confers protection against aortic aneurysms and dissections. Circ Res 112(4):618-632, 2013.
89. Shyu KG, Chen SC, Wang BW, Cheng WP, Hung HF. Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells. Clin Sci (Lond) 122(1):33-42, 2012.
90. Simard JC, Simon MM, Tessier PA, Girard D. Damage-associated molecular pattern S100A9 increases bactericidal activity of human neutrophils by enhancing phagocytosis. J Immunol 186(6):3622-3631, 2011.
91. Su X, Ao L, Shi Y, Johnson TR, Fullerton DA, Meng X. Oxidized low density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via Toll-like receptors 2 and 4. J Biol Chem 286(14):12213-12220, 2011.
92. Subramanian V, Golledge J, Heywood EB, Bruemmer D, Daugherty A. Regulation of peroxisome proliferator-activated receptor-gamma by angiotensin II via transforming growth factor-beta1-activated p38 mitogen-activated protein kinase in aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 32(2):397-405, 2012.
93. Tabernero J, Shapiro GI, Lorusso PM, Cervantes A, Schwartz GK, Weiss GJ, Paz-Ares L, Cho DC, Infante JR, Alsina M, Gounder MM, Falzone R, Harrop J, White AC, Toudjarska I, Bumcrot D, Meyers RE, Hinkle G, Svrzikapa N, Hutabarat RM, et al. First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov 3(4):406-417, 2013.
94. Tadin-Strapps M, Peterson LB, Cumiskey AM, Rosa RL, Mendoza VH, Castro-Perez J, Puig O, Zhang L, Strapps WR, Yendluri S, Andrews L, Pickering V, Rice J, Luo L, Chen Z, Tep S, Ason B, Somers EP, Sachs AB, Bartz SR, et al. siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids. J Lipid Res 52(6):1084-1097, 2011.
95. Thompson MM, Boyle JR, Crowther M, Goodall S, Wills A, Loftus IM, Bell PR. Therapeutic options in small abdominal aneurysms: the role of in vitro studies. Ann N Y Acad Sci 878:724-727, 1999.
96. Thompson RW, Baxter BT. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Ann N Y Acad Sci 878:159-178, 1999.
97. Thompson RW, Liao S, Curci JA. Therapeutic potential of tetracycline derivatives to suppress the growth of abdominal aortic aneurysms. Adv Dent Res 12(2):159-165, 1998.
98. Turner EC, Huang CL, Govindarajan K, Caplice NM. Identification of a Klf4-dependent upstream repressor region mediating transcriptional regulation of the myocardin gene in human smooth muscle cells. Biochim Biophys Acta 1829(11):1191-1201, 2013.
99. Vandenbroucke St Amant E, Tauseef M, Vogel SM, Gao XP, Mehta D, Komarova YA, Malik AB. PKCalpha activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity. Circ Res 111(6):739-749, 2012.
100. Vuong PT, Malik AB, Nagpala PG, Lum H. Protein kinase C beta modulates thrombin-induced Ca2+ signaling and endothelial permeability increase. J Cell Physiol 175(3):379-387, 1998.
101. Wang J, An FS, Zhang W, Gong L, Wei SJ, Qin WD, Wang XP, Zhao YX, Zhang Y, Zhang C, Zhang MX. Inhibition of c-Jun N-terminal kinase attenuates low shear stress-induced atherogenesis in apolipoprotein E-deficient mice. Mol Med 17(9-10):990-999, 2011.
102. Wang L, Hu X, Zhang W, Tian F. Angiotensin (1-7) ameliorates angiotensin II-induced inflammation by inhibiting LOX-1 expression. Inflamm Res 62(2):219-228, 2013a.
103. Wang X, Li L, Li M, Dang X, Wan L, Wang N, Bi X, Gu C, Qiu S, Niu X, Zhu X, Wang L. Knockdown of mTOR by lentivirusmediated RNA interference suppresses atherosclerosis and stabilizes plaques via a decrease of macrophages by autophagy in apolipoprotein Edeficient mice. Int J Mol Med 32(5):1215-1221, 2013b.
104. Xu B, Zhou Y, O K, Choy PC, Pierce GN, Siow YL. Regulation of stress-associated scaffold proteins JIP1 and JIP3 on the c-Jun NH2-terminal kinase in ischemia-reperfusion. Can J Physiol Pharmacol 88(11):1084-1092, 2010.
105. Yan FF, Liu YF, Liu Y, Zhao YX. KLF4: a novel target for the treatment of atherosclerosis. Med Hypotheses 70(4):845-847, 2008.
106. Yao S, Zong C, Zhang Y, Sang H, Yang M, Jiao P, Fang Y, Yang N, Song G, Qin S. Activating transcription factor 6 mediates oxidized LDL-induced cholesterol accumulation and apoptosis in macrophages by up-regulating CHOP expression. J Atheroscler Thromb 20(1):94-107, 2013.
107. Yu M, Kang X, Xue H, Yin H. Toll-like receptor 4 is up-regulated by mTOR activation during THP-1 macrophage foam cells formation. Acta Biochim Biophys Sin (Shanghai) 43(12):940-947, 2011.
108. Yu SS, Lau CM, Barham WJ, Onishko HM, Nelson CE, Li H, Smith CA, Yull FE, Duvall CL, Giorgio TD. Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles. Mol Pharm 10(3):975-987, 2013.
109. Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101(1):25-33, 2000.
110. Zhang H, Chen J, Liu X, Awar L, Mcmickle A, Bai F, Nagarajan S, Yu S. IL-17 induces expression of vascular cell adhesion molecule through signalling pathway of NF-kappaB, but not Akt1 and TAK1 in vascular smooth muscle cells. Scand J Immunol 77(4):230-237, 2013a.
111. Zhang K, Huang XZ, Li XN, Feng M, Li L, Cai XJ, Zhang C, Liu XL, Zhang MX, Zhang Y, Wang XL, Zhang M. Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase alpha1 via a mitogen-activated protein kinase and c-Jun pathway. Arch Biochem Biophys 528(2):127-133, 2012.
112. Zhang Z, Zhang M, Li Y, Liu S, Ping S, Wang J, Ning F, Xie F, Li C. Simvastatin inhibits the additive activation of ERK1/2 and proliferation of rat vascular smooth muscle cells induced by combined mechanical stress and oxLDL through LOX-1 pathway. Cell Signal 25(1):332-340, 2013b.